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In this study healthy never-smoking subjects (n= 18) were recruited from a population study. Bronchoalveolar 
lavage (BAL), blood lymphocytes and bronchial biopsies, analysed both in the epithelium and lamina propria, were 
stained for T and B lymphocytes, natural killer (NK) cells and different subpopulations of T lymphocytes. In BAL, 
significantly higher proportions of T lymphocytes (CD3), T lymphocyte activation markers; HLA-DR, CD26+, 
CD49a+, CD54+ and CD69+, helper T (CD3+4+) and memory helper T lymphocytes (CD4+45R0+29+) and 
memory T lymphocytes (CD3+45ROf) were found, compared to blood. However, the proportion of IL-2 receptor- 
positive T lymphocytes (CD25+) was lower in BAL than in blood. A previously described higher ratio of CD3+4+/ 
CD3+ 8+ in BAL than in blood ( 3.4 vs 1.7; P= 0.001) was confirmed. In bronchial biopsies, we found significantly 
higher numbers of CD8+ cell profiles per mm’ in the epithelial compared to the lamina propria compartment. 
We conclude that healthy never-smoking men have higher levels of activated memory T lymphocytes in BAL 
than in blood, and that the T-cell subpopulations differ in the epithelial compared to the lamina propria 
compartment in the bronchial mucosa and these compartments should be analysed separately. It is reasonable to 
think that there is a gradient from blood to the airway lumen where T cells are recruited from blood to take part in 
the defense towards damaging agents. 
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Introduction 
On the alveolar surface the external environment contain- 
ing micro-organisms and other antigens is only a short 
distance from the blood. The major part of the antigenic 
load of the inhaled air is removed through the action of the 
mucociliary clearence of the conducting airways. A small 
fraction will reach the alveolus and interact with cells; 
alveolar macrophages, lymphocytes and alveolar epithelial 
cells. It has been suggested that pulmonary T cells mediate 
antigen-specific effector functions and, with other pulmon- 
ary immunocompetent cells, secrete cytokines and other 
biological response modifiers which favour the tissue 
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Furthermore, the important airway biopsy studies have 
described the lymphocyte subpopulations in lamina propria 
(2,3,5) only a few earlier studies have investigated 
lymphocyte subpopulations in the epithelium (6,7). 
Lymphocytes in the bronchial lamina propria have been 
shown to be mainly T lymphocytes and very low levels 
of B-lymphocytes and natural killer (NK) cells have 
been detected in the mucosa of central airways (3,6). Both 
CD4- and CD&positive T lymphocytes have been 
detected with a small dominance of CD8-positive cells. 
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localization and activation of newly recruited antigen- 
specific memory cells (1). 
Most earlier studies have analysed the expression of 
lymphocyte surface markers in bronchial biopsies, bronch- 
oalveolar lavage (BAL) or blood in patients with asthma or 
chronic bronchitis. Often only a relatively low number of 
healthy non-smokers were included as controls (2-4). 
However, no previous study has focused on life-long 
never-smokers and compared lymphocyte subpopulations 
in both bronchial biopsies, BAL and blood from each 
subject. 
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Lymphocytes in BAL have been shown to have a higher 
frequency of activation markers and memory cell markers 
than those in blood (4, 8). 
Our hypothesis was that lymphocytes found in BAL are 
functional and act together with cells of the innate immune 
system as a first line of defence against inhaled damaging 
agents. Therefore, we studied activation and proliferation 
markers of T lymphocytes in the blood and BAL 
compartments and compared them with bronchial biopsy 
material divided into the epithelium and lamina propria 
compartments. 
Materials and Methods 
SUBJECTS 
The subjects were recruited from the population study 
‘Men born 1933 in Gdteborg’ where 1016 men were studied 
in 1983 (9). In total, 879 men were called for a new 
evaluation in 1993. Of these, 532 were evaluated with 
spirometry. When the subjects were divided according to 
smoking habits, 112 were smokers, 198 were never-smokers 
and 222 ex-smokers. A random sample of 60 never-smokers 
was chosen for a lung examination. The result was that 34 
never-smokers were included and, of these, 18 men agreed 
to undergo bronchoscopy, while 15 did not want to take 
part in the study. 
Subjects were included if they were healthy and had not 
sought medical attention for any pulmonary problem. 
Subjects were excluded if they 1. had any pulmonary 
problem, 2. had scoliosis or other diseases with deforma- 
tion of the thorax, 3. had a history of congestive heart 
failure or unstable angina pectoris, 4. had any other severe 
disease, 5. if they had any kind of infection during the 4 
weeks preceeding the examination or 6. if they had been on 
cortocosteroid, N-acetylcysteine (NAC) or acetylsalicylic 
acid (ASA) treatment less than 4 weeks prior to blood tests 
or bronchoscopy (with the exception of those persons with 
a prior heart infarction). A total of 11 subjects were 
excluded. 
The study was approved by the Ethics Committee at 
Sahlgrenska University Hospital, Goteborg, Sweden. 
FIBRE-OPTIC BRONCHOSCOPY AND 
COLLECTION OF SAMPLES 
Premeditation with diazepam 5 mg orally was followed by 
0.5 ml morphine-scopolamin i.m., except if the subject had 
a history of kidney or gall bladder disease in which case 
petidine 75 mg i.m. and atropine 0.5 mg S.C. were given 
instead. Additional i.v. diazepam was also given during the 
bronchoscopic procedure in some subjects. 
All subjects were given terbutalin 0.25 mg dose- ’ 2 x 3 in 
a nebulizer to avoid unexpected bronchoconstriction 
during the procedure. Local anaesthesia was achieved 
initially with 1% tetracaine spray in the mouth and 
laryngeal tract; additional anaesthesia was applied through 
the bronchoscope channel for the lower respiratory tract. A 
bronchoscopy was taken trans-orally with an Olympus 
flexible fibre-optic bronchoscope (Tokyo, Japan). The 
subject was examined in a supine position by one 
experienced bronchoscopist (A.E.J.). Two subjects were 
examined by another experienced bronchoscopist (C.G.L.). 
Oxygen saturation was measured with an Ohmeda Pulse 
Oximeter (Louisville, U.S.A.) during the bronchoscopy and 
supplemental oxygen at a rate of 2-3 1 min- ’ was given 
through a nasal catheter when needed. 
All bronchoscopies were performed between 0830 and 
1000 hours. Bronchoalveolar lavage (BAL) was performed 
as follows: 3 x 50 ml of phosphate- buffered saline (PBS) 
was instilled through the bronchoscope channel into the 
middle lobe with the bronchoscope in a wedged position 
and suction was performed after each portion of PBS into 
siliconized bottles placed on ice. The samples were then 
transported to the laboratory for analysis. Recovery was 
measured and the fluid filtered through a nylon web with a 
pore size of 100 pm for retention of mucus and cell debris. 
The lavage fluid was then centrifuged at 250 g for 10 min at 
4°C. The supernatant was separated, and the cell pellet was 
resuspended in PBS. The total number of cells in BAL was 
determined by using a haemocytometer. Cell viability was 
estimated by means of trypan blue exclusion. Calculation of 
cell differentials was done on cytocentrifuged preparations 
(Cytospin 2; Shandon Southern Products Ltd., Runcorn, 
U.K.) stained with May-Grtinwald-Giemsa and after 
counting 1000 cells. BAL was performed during all 
bronchoscopies, but in one case the BAL could not be 
evaluated due to a high amount of debris which made the 
flow cytometry analysis impossible to interpret. 
Peripheral bronchial biopsies (334 biopsies per subject) 
were also taken in the lower left lobe with alligator forceps. 
The biopsies were gently removed from the forceps, 
immediately placed in a sterile, moist chamber and were 
transported to the laboratory for further processing. Ten 
biopsies were evaluable, while eight could not be evaluated. 
In one of the 18 subjects no biopsy material was obtainable, 
while in seven, no histologically evaluable biopsy material 
was obtained. Two more biopsies did not give an adequate 
CD69 staining in the epithelium and the results from 
both the epithelium and lamina propria were therefore 
excluded. The subjects in the eight unevaluable biopsies did 
not differ in sex, age or lung function, except for DLCO (% 
pred.), compared to the subjects giving evaluable biopsies 
(Table 1). 
FLOW CYTOMETRY 
Subpopulations of lymphocytes in BAL and blood were 
determined by flow cytometry. The samples were stained 
with combinations of murine monoclonal antibodies, 
directly conjugated with fluorochromes (fluorescein 
isothiocyanate, phycoerythrine or Per-CP) or with 
a biotinconjugated antibody and streptavidin conjuga- 
ted with Per-CP. BAL cells (1 x 10’ cells sample-‘) 
and whole blood (with EDTA as an anticoagulant in 
a volume corresponding to about 5 x lo5 cells antibody 
staining-‘) were incubated at 4°C for 15 min with 
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TABLE 1. Lung function - descriptive statistics 
Evaluable Unevaluable 
biopsies biopsies 
(n= 10) (n=8) P* 
TLC (% pred.) 98&13 98f 12 n.s. 
RV (% pred.) 102f36 86* 10 ns. 
VC (% pred.) 92* 9 102 f 14 n.s. 
FEVi (% pred.) 105* 9 114*19 n.s 
DLCO (% pred.) 88*12 107 * 14 o-01 
DLCO VA-’ (% pred.) 88% 7 97&14 n.s 
Nz test (% pred.) 108f47 72& 30 n.s. 
Data are given as mean &SD. 
*P according to Mann-Whitney<<U-test; ns. not significant 
antibodies in the concentrations recommended by the 
manufacturer. 
The following fluorescein isothiocyanate-conjugated 
antibodies were used: CD4, CD25 CD44, CD45RA, 
CD69, TCRafi (Becton-Dickinson Inc., Mountain View, 
CA, U.S.A.); CD26 (Coulter Corporation, Miami, FL, 
U.S.A.); CD29 (Dakppatts A/S, Glostrup, Denmark); 
CD49a and TCR y6 (T Cell Diagnostics Inc., Cambridge, 
MA, U.S.A.). The following phycoerythrin-conjugated 
antibodies were used: CD8, CD25, CD28, CD38, 
CD45R0, CD54, CD56+ CD16, HLA-DR and 62L 
(Becton-Dickinson Inc.). The Per-CP-conjugated antibo- 
dies CD3, CD4 and CD19 and Per-CP-conjugated 
streptavidin were used (Be&on-Dickinson Inc.). The CDS 
biotinylated antibody was used: (Becton-Dickinson Inc.). 
Cell analysis was done on a fluorescence activated cell 
sorter (FACScan) flow cytometer (Becton-Dickinson Inc.), 
calibrated with CALIBRITETM beads (Becton-Dickinson 
Inc.) and AutoCOMPTM software (Becton-Dickinson Inc.). 
A lymphocyte gate was set manually according to the 
location in the forward-scatter versus side-scatter diagram. 
Negative isotype controls (Becton-Dickinson Inc.) were 
used to set quadrant markers which delineated positive 
fluorescent staining from non-antigen specific staining. 
Dot plots and quadrant statistics from three-colour analysis 
were generated by Lysis II software (Becton-Dickinson 
Inc.). The absolute number of blood lymphocytes was 
determined using a haematological cell counter (Sysmex- 
KlOOO; TOA Medical Electronics Co, Japan). In a majority 
of the BAL samples it was difficult to discriminate events 
representing lymphocytes from events due to debris in the 
forward-scatter versus side-scatter diagram. To compensate 
for this, all percentages of lymphocyte subpopulations from 
BAL and blood from each individual were divided by 
the percentages of cells positive for CD45 and negative for 
CD14, which represent all major lymphocyte populations. 
These adjusted values were then used in all calculations. 
The results for each subpopulation were expressed as 
the percentage of lymphocytes or percentage of T 
lymphocytes in BAL and as the percentage of lymphocytes 
or percentage of T lymphocytes and as the number of 
cells x 10’ 1-l in blood. 
IMMUNOHISTOCHEMISTRY 
Biopsies were oriented using a dissection microscope in 
order to obtain perpendicular sections including both 
epithelium and lamina propria. They were then embedded 
in Tissue Tek II OCT (Miles Scientific, Naperville, IL, 
U.S.A.), immediately frozen in isopenthane pre-cooled in 
liquid nitrogen and stored at - 70°C. The biopsies were cut 
with a cryostat (Kryostat 1720 Digital, Leitz, Germany) 
into 5-pm thick sections and placed on gelatin-coated 
slides. One section from each biopsy was fixed in formalin 
alcohol and was stained by Mayer’s haematoxylin, lithium 
carbonate and eosin. Only biopsies with intact epithelium 
and lamina propria were subject to immunohistochemistry. 
Five sections were taken 30-40 pm apart and were put on a 
gelatin-coated slide for each staining. The sections were 
stored at - 20°C before immunohistochemistry staining 
was performed. 
An indirect immunoperoxidase protocol was used 
and the optimal dilutions of reagents were determined 
using bronchial and tonsil tissue, as well as phythaemag- 
glutinin (PHA) stimulated blood lymphocytes. Briefly, the 
sections were brought to room temperature, fixed 
in acetone and air-dried. Sections were rehydrated in PBS 
and incubated with the primary antibody. The following 
primary monoclonal antibodies and concentrations 
were used: CD3 (2.1 pg ml-‘), CD4 (1.7 pg ml-‘), CD8 
(1 pg ml-‘) (DAKOPATTS A/S, Glostrup, Denmark) 
and CD69 (0.67 pg ml-‘, Caltag Laboratories, 
San Fransisco, CA, U.S.A.). After incubation for 1 h at 
room temperature and washing three times in PBS, 
the slides were further processed in an automatic staining 
machine (Cadenza; Shandon Scientific Ltd, Cheshire, 
U.K.). After washing in PBS the slides were incubated 
for 1 h at room temperature with a biotinylated rabbit 
anti-mouse immunoglobulin antibody (Fab E413, 4 pg 
ml-‘, DAKOPATTS A/S) diluted in PBS with 1% bovine 
serum albumin (BSA) (Sigma, St. Louis, MO, U.S.A.) 
and 1% human serum. After another washing in PBS, 
endogenous peroxidase activity was blocked with 0.3% 
Hz02 (E. Merck, Darmstadt, Germany) in PBS for 5 min 
in the dark. After washing in PBS, the slides were incubated 
with streptABComplex/HRP Duet (DAKOPATTS 
A/S) for 1 h. After a final wash in PBS, 3-amino-9- 
ethylcarbazole (AEC, Sigma), 33 pg ml-’ diluted in 0.02~ 
sodium acetate buffer (E. Merck), pH 5.5, with 12% 
dimethylsulphoxide (DMSO) and 0.5% Hz02 was added as 
substrate. The reaction was stopped after 8-15 min with 
distilled water for optimal colour and development. 
Counterstaining was performed with Mayer’s haematox- 
ylin. The slides were mounted in an aqeuous medium 
(Aquatex, E. Merck) . 
The density of labelled cells, estimated as the number of 
positive cell profiles per mm2 in each section, was 
determined using a light microscope (Axioplan, Carl Zeiss 
Jena GmgH, Jena, Germany), connected to a digital 
camera (Prog/Res 3012, Kontron Elektronik GmbH, 
Eching, Germany) and connected to a computer ( Kontron 
Elektronik GmbH, Eching, Germany). Cell profiles per 
mm2 were estimated using an interactive image analysis 
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system (IBAS version 2.5, Kontron Elektronik GmbH). 
Object magnification was x 40. 
The sections were analysed separately in an epithelial and 
a lamina propria compartment. In the epithelial compart- 
ment the whole available area and in the lamina propria 
TABLE 2. Recovery and cell viability in BAL. Cell 
populations in BAL 
Never-smokers 
(n= 17) 
Total number of cells in BAL (x 106) 6.0 (0.2-18) 
Cell concentration in BAL 8.5 (2.5-20.0) 
( x 1 04cells ml - ‘) 
Recovery in BAL (ml) 85 (5&120) 
Cell viability in BAL (alive dead-‘, %) 76 (43-86) 
Cell differential counts BAL (%) 
Macrophages 90 (75-96) 
Lymphocytes 6 (O-23) 
Neutrophils 2 (l-5) 
Eosinophils 1 (@3) 
Data are given as median (range). 
compartment the area between 0 and 100 pm below the 
basement membrane was analysed. Lymphocytes were 
counted as positive if they had a nuclear profile surrounded 
by a distinctly coloured cell membrane. Lymphocytes with 
only segments of a membrane were not counted and 
membranes without a nuclear profile were excluded. 
DATA ANALYSIS 
As data for lymphocyte subpopulations are not normally 
distributed, group data are presented with their median and 
range. For lung function variables mean and standard 
deviation (SD) are presented. We assumed that the data 
were not evenly distributed, therefore we used the non- 
parametric Mann-Whitney U-test to analyse differences 
between the groups. We used Abacus Concepts Stat View 
4.5@ (Abacus Concepts, Inc., Berkeley, CA, U.S.A., 1994) 
for statistical calculations. 
Results 
COMPARISON OF LYMPHOCYTE 
SUBPOPULATIONS IN BAL AND BLOOD 
Total cells, cell concentration, cell viability and cell 
differential counts in BAL are shown in Table 2. To 
TABLE 3. Comparison of percentages of lymphocyte subpopulations in BAL and blood 
BAL (n= 17) 
Cell population Surface antigen Median (range) 
Blood (n = 34) 




T lymphocyte subpopulations 
T cell receptor c$ 
T cell receptor y6 
Unprimed cell 
Memory cell 
Memory helper T cell 
Helper/inducer cell 
Cytotoxic/supressor cell 
Helper/ cytotoxic ratio 
Activated T cell 
Activated T cell 
Activated T cell 
Activated T cell 
Activated T cell 
Activated T cell 
Activated T cell 
Activated T cell 
Activated T cell 
Activated T cell 
Activated T cell 
Activated T cell 
CD3 + 89 (79-97) 72 (57-92) o*ooo 1 
CD19+ 0 (O-3) 8 (2-20) o*ooo 1 
CD3-56 + 3 (GIO) 13 (3-30) o*ooo 1 
CD3 + TCRo$ 97 (84-103) 94 (70-104) n.s. 
CD3 ‘TCR y6 2 (l-8) 3 (l-24) ns. 
CD3+45RA+ 29 (657) 58 (3698) 0~0001 
CD3+45RO+ 96 (62-107) 66 (48-84) 0~0001 
CD4+ 45R0+29+ 75 (33-89) 43 (5-66) 0.000 1 
CD3+4+ 75 (39-90) 62 (37-80) O*OOl 
CD3+8+ 21 (l&59) 36 (1666) 0.01 
CD3+4+/CD3+8+ 3.4 (0.7-7.5) 1.7 (0.65.1) 0.001 
CD3+DR+ 86 (65-104) 26 (5-96) 0.000 1 
CD3+25+ 11 (O-41) 25 (8-81) 0.002 
CD3+26+ 12 (l-70) 2 (O-30) 0.0005 
CD3+28+ 75 (10-95) 75 (50-96) ns. 
CD3+38+ 17 (5-55) 52 (19-72) o*ooo 1 
CD3+44+ 100 (94-106) 99 (9&105) n.s. 
CD3+49a+ 46 (22-72) 1 (O-36) 0.000 1 
CD3+ 54+ 82 (29-100) 30 (10-77) 0.000 1 
CD3+57+ 17 ((r50) 15 (8-39) . . 
CD3+69+ 80 (52-94) 2 (O-13) o.;oso1 
CD3+62L+ 18 (4-56) 70 (34-89) 0~0001 
CD3+56+16+ 2 (O-l 1) 2 (O-13) ns. 
Data are give as median (range). 
*P according to the Mann-Whitney U-test, ns., not significant. 
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analyse possible differences in the distribution of major The helper T lymphocytes (CD3+4+) were found in 
lymphocyte subpopulations in BAL and blood, the higher proportions in BAL than in blood (Table 3). The 
proportions in BAL and blood were compared (Table 3). mean ratio of CD3+4+/CD3+8+ was 3.4 in BAL and 1.7 
The proportion of T lymphocytes (CD3) was significantly in blood and the difference was highly significant. The 
higher in BAL than in blood, while the proportions of B proportions of memory T (CD3+45ROf) and memory 
lymphocytes and NK cells were significantly lower in BAL helper T (CD4+45R0+29+) lymphocytes were signifi- 
than in blood . cantly higher in BAL, and that of unprimed T lymphocytes 
TABLE 4. Lymphocyte subpopulations in different compartments of bronchial biopsies from never-smokers 
Lymphocyte 
subpopulations 
Density of labelled cells Number of counted cells Estimated tissue area 
(profiles mme2) (profiles/subject - ‘) (mm2 subject-‘) 





















77 n.s. (9-144) 0.14 (0*060~21) 
111 (46-303) 0.22 (0*10~41) 
35 0.13 
(y.‘G 30 (2-234) 1 183 0.23 (O-05-0.27) .llH.37) 
62 (O-164) 0.13 (0*0&0*31) 
ns. 
35 (2-234) O-24 (O-12-0.70) 
41 (2-145) 0.12 (0.04-0.25) 
16 (l-245) 0.21 (0*1&0*39) 
P according to Mann-Whitney U-test; n.s., not significant. 
FIG. 1. Photomicrograph of a bronchial biopsy from a healthy never-smoking subject showing CD8-positive lymphocytes in 
the epithelial compartment. 
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Lamina propria Epithelium 
Lamina propria Epithelium 
FIG. 2. Cell density/mmp2 of CD3’, CD4+, CD8+ and CD69’ 
according to the Mann-Whitney U-test; ns., not significant). 
(CD3+45RA+) was significantly lower in BAL than in 
blood, 
Significantly higher proportions of some of the activation 
markers, HLA-DR, CD26, CD49a, CD54 and CD69, were 
seen in BAL (Table 3). However, the proportion of IL-2 
receptor-positive T lymphocytes (CD3 +25+) was lower in 
BAL than in blood, indicating that IL-2 dependant 
proliferation was downregulated. L-selectin-positive 
(CD3+62Lt) and CD38-positive T lymphocytes were also 
found in lower proportions in BAL than in blood. 
COMPARISON OF LYMPHOCYTE SURFACE 
MARKERS IN RESPIRATORY EPITHELIUM 
AND LAMINA PROPIA OF BRONCHIAL 
BIOPSIES 
The distribution of lymphocyte subpopulations expressed 
as density of labelled cells (profiles mm-‘), the number of 
counted cells (profiles subject-‘) and the estimated tissue 
area (mm2 subject-‘), in the epithelial and the lamina 
propria compartments in bronchial biopsies, are shown in 
Table 4. The number of CD8 positive cell profiles per mm2 
was significantly higher in the epithelial than in the lamina 
propria compartment (518 vs. 212; P=O.O4) (Fig.1). There 
were no significant differencies between the two compart- 
ments for CD3 positive, CD4 positive or CD69 positive cell 
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cells in the epithelium and lamina propria compartment (P 
Discussion 
The aim of this study was to test the hypothesis that 
lymphocytes found in BAL in healthy subjects are 
accumulated memory cells recruited from blood. The study 
was performed on a group of healthy never-smoking men 
of about 60 years of age. It was unique in the sense that all 
subjects were men, born in the same year and recruited 
from the same population. In contrast to earlier biopsy 
studies performed on a limited number of healthy non- 
smoking subjects, our study included 18 subjects 
(2,3,6,10). Previous studies on lymphocyte subpopulations 
in bronchoalveolar lavage of healthy subjects have been 
performed on young subjects (4,ll). The present study has 
focused on older subjects. In order to analyse the possible 
recruitment and migration of lymphocytes into the airways, 
we analysed the lymphocyte subpopulations in blood and 
bronchial mucosa as well as in BAL. 
When the distribution of lymphocyte subpopulations in 
BAL was compared to that in blood a higher frequency was 
found of T lymphocytes (CD3), T helper lymphocytes 
(CD3+4+), T memory lymphocytes (CD3+45RO+), and a 
lower frequency of B lymphocytes (CD19) and NK cells 
(CD3-56+). This is in agreement with previous studies (4). 
Further a previously described higher ratio in BAL of 
CD3+4+/CD3+8+ was confirmed (8). 
Earlier studies have described a higher frequency of 
memory helper T lymphocytes (CD4+45R0+29+) in BAL 
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than in blood (4,12). This was also seen in our study. After 
local immunization in the lung it has been shown that the 
main antibody production occurs locally and has the 
characteristics of a memory response (13,14). It is reason- 
able to think that the high frequency of memory cells in 
BAL represent a local accumulation of lymphocytes 
directed against antigens frequently occurring in the 
airways. The blood population, on the other hand, has a 
high frequency of unprimed and unactivated naive lym- 
phocytes. 
In general, lymphocyte function can be analysed in vitro 
by direct stimulation and measurement of proliferation, 
surface marker expression or cytokine production. It is 
technically difficult to obtain enough pure lymphocytes 
from human lungs to perform a direct stimulation. In this 
study, in vivo cell surface marker expression was analysed to 
obtain indirect information about activation. Early (CD69) 
as well as later (HLA-DR, CD26, CD49a and CD54) 
activation markers were found in a much higher frequency 
on BAL lymphocytes than on blood lymphocytes in our 
healthy never-smoking subjects. These findings indicate 
that lymphocytes in the bronchoalveolar space are also 
recruited and activated in healthy never-smokers. Evidence 
for this was found in data from our bronchial biopsies. 
In the biopsies, we chose to evaluate those T-lymphocyte 
markers which were different in BAL and blood, i.e. CD3, 
CD4, CDS, and the early activation marker CD69. An 
earlier study have described a predominance of CD8- 
positive over CD4-positive lymphocytes in both the 
epithelium and the lamina propria and our results agree 
with this (6). There was a higher number of cytotoxic T 
lymphocytes (CD8) profiles per mm2 and a similar tendency 
for helper T lymphocytes (CD4) in the epithelial compart- 
ment compared to the lamina propria compartment in our 
study. A recent study by Kraft et al. (15) showed 
significantly greater numbers of, e.g., CD4 lymphocytes in 
the proximal airway lamina propria biopsies than in distal 
alveolar tissue transbronchial biopsies in patients with 
nocturnal asthma. Only alveolar tissue, not airway tissue, 
CD4-positive cells correlated inversely with lung function 
(FEVr), however. We have not performed any comparison 
with distal alveolar tissue transbronchial biopsies. Our data 
do, however, support the hypothesis that there is a 
migration of lymphocytes from blood towards the bronch- 
oalveolar space possibly induced by a chemotactic stimulus. 
Such a migration has been described in sensitized mice (16). 
Masuyama et al. (17) showed that T cells from human 
blood migrating through a monolayer of cultured human 
endothelial cells in vitro had signs of recent activation as 
well as of long term-activation. If a similar mechanism 
occurs in the bronchi, the expression of the early activation 
marker CD69 could be due to recent passage through the 
vessel endothelium. After in vitro stimulation, CD69 has 
been found on most haematopoetic cells, including 
lymphocytes. This has been described in the bronchial 
mucosa of mice, but the present study is the first to decribe 
it in humans (16). 
A hypothesis has been presented suggesting that activa- 
tion of pulmonary lymphocytes (e.g. increased CD69) does 
not lead to proliferation (18, 19). In an animal study, Paine 
et al. (19) and Holt et al. (20) showed that rat alveolar 
epithelial cells and alveolar macrophages, respectively, 
inhibited proliferation but not other functions of activated 
lymphocytes, e.g. cytokine production and upregulation of 
surface adhesion molecules. In a human study, Mukae et al. 
(18) detected signs of T-lymphocyte activation without 
signs of T-lymphocyte proliferation (unchanged levels of 
CD25) in bronchiolitis obliterans organizing pneumonia 
and chronic eosinophilic pneumonia patients. In our study, 
the frequency of the IL-2 receptor (CD25) was not higher 
but lower in BAL as compared to blood. As proliferating 
lymphocytes upregulate the expression of CD25 this agrees 
with the hypothesis that BAL lymphocytes can be activated 
without proliferation. This suggests that cells of the 
bronchoalveolar surface downregulate clonal expansion of 
local lymphocytes. A clonal expansion should not take 
place until the lymphocytes have migrated to a local 
lymphoid tissue where the expansion would not cause 
functional damage. 
In summary, our study shows that healthy never-smokers 
have a higher frequency of CD8 $- T lymphocytes in the 
epithelial than in the lamina propria compartment in 
bronchial biopsies. BAL lymphocytes have a higher 
frequency of activated memory cells than blood lympho- 
cytes. It is resonable to suggest that these lymphocytes have 
been recruited in response to exposure to local damaging 
agents. Thus, even in healthy never-smokers there are active 
T lymphocytes in the alveoli and broncial mucosa which 
can be part of a first line of defence against inhaled 
damaging agents. 
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